G C Alfsen

Summary

Affiliation: University of Oslo
Country: Norway

Publications

  1. ncbi request reprint Histopathologic subtyping of cervical adenocarcinoma reveals increasing incidence rates of endometrioid tumors in all age groups: a population based study with review of all nonsquamous cervical carcinomas in Norway from 1966 to 1970, 1976 to 1980, and 19
    G C Alfsen
    Department of Pathology, The Norwegian Radium Hospital, Oslo, Norway
    Cancer 89:1291-9. 2000
  2. ncbi request reprint Reproducibility of classification in non-squamous cell carcinomas of the uterine cervix
    G Cecilie Alfsen
    Department of Pathology, Norwegian Radium Hospital, N 0310 Oslo, Norway
    Gynecol Oncol 90:282-9. 2003
  3. ncbi request reprint The prognostic impact of cyclin dependent kinase inhibitors p21WAF1, p27Kip1, and p16INK4/MTS1 in adenocarcinomas of the uterine cervix: an immunohistochemical evaluation of expression patterns in population-based material from 142 patients with internati
    G Cecilie Alfsen
    Department of Pathology, The Norwegian Radium Hospital, Oslo, Norway
    Cancer 98:1880-9. 2003
  4. ncbi request reprint Histologic subtype has minor importance for overall survival in patients with adenocarcinoma of the uterine cervix: a population-based study of prognostic factors in 505 patients with nonsquamous cell carcinomas of the cervix
    G C Alfsen
    Department of Pathology, The Norwegian Radium Hospital, N 0310 Oslo, Norway
    Cancer 92:2471-83. 2001
  5. pmc Late recurrences of germ cell malignancies: a population-based experience over three decades
    J Oldenburg
    Faculty of Medicine, University of Oslo, Oslo, Norway
    Br J Cancer 94:820-7. 2006

Detail Information

Publications5

  1. ncbi request reprint Histopathologic subtyping of cervical adenocarcinoma reveals increasing incidence rates of endometrioid tumors in all age groups: a population based study with review of all nonsquamous cervical carcinomas in Norway from 1966 to 1970, 1976 to 1980, and 19
    G C Alfsen
    Department of Pathology, The Norwegian Radium Hospital, Oslo, Norway
    Cancer 89:1291-9. 2000
    ..The effect of histopathologic review and subclassification on incidence rates for nonsquamous cell carcinoma (non-SCC) of the uterine cervix in the Norwegian population was evaluated...
  2. ncbi request reprint Reproducibility of classification in non-squamous cell carcinomas of the uterine cervix
    G Cecilie Alfsen
    Department of Pathology, Norwegian Radium Hospital, N 0310 Oslo, Norway
    Gynecol Oncol 90:282-9. 2003
    ..The reproducibility of histologic classification of non-squamous carcinomas (non-SCC) of the uterine cervix was evaluated, using population-based material from two 5-year periods in Norway...
  3. ncbi request reprint The prognostic impact of cyclin dependent kinase inhibitors p21WAF1, p27Kip1, and p16INK4/MTS1 in adenocarcinomas of the uterine cervix: an immunohistochemical evaluation of expression patterns in population-based material from 142 patients with internati
    G Cecilie Alfsen
    Department of Pathology, The Norwegian Radium Hospital, Oslo, Norway
    Cancer 98:1880-9. 2003
    ..The authors assessed the prognostic significance of abnormal cyclin dependent kinase inhibitor (CDKI) expression in adenocarcinomas of the uterine cervix...
  4. ncbi request reprint Histologic subtype has minor importance for overall survival in patients with adenocarcinoma of the uterine cervix: a population-based study of prognostic factors in 505 patients with nonsquamous cell carcinomas of the cervix
    G C Alfsen
    Department of Pathology, The Norwegian Radium Hospital, N 0310 Oslo, Norway
    Cancer 92:2471-83. 2001
    ..The incidence of adenocarcinoma of the uterine cervix is increasing. For better prognostic information, the authors studied all nonsquamous cell carcinomas (non-SCCs) in the Norwegian population over a total of 15 years...
  5. pmc Late recurrences of germ cell malignancies: a population-based experience over three decades
    J Oldenburg
    Faculty of Medicine, University of Oslo, Oslo, Norway
    Br J Cancer 94:820-7. 2006
    ..The 10-year incidence rate of late relapses of 1.3% might reflect the true incidence rate in a population-based cohort of MGCT patients, with cure in at least half of them...